![]() |
市場調查報告書
商品編碼
1784657
2021-2031年亞太地區醫用電纜市場報告(範圍、細分、動態和競爭分析)Asia Pacific Medical Cables Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis |
亞太地區醫療電纜市場規模預計將從 2023 年的 22.091 億美元增至 2031 年的 35.7901 億美元。預計 2023 年至 2031 年期間該市場的複合年成長率為 6.2%。
執行摘要和亞太醫療電纜市場分析:
由於對先進醫療設備和醫療保健技術創新的需求不斷成長,亞太地區醫療電纜市場正在經歷顯著成長。該地區醫療基礎設施的不斷改進以及老齡人口的不斷成長,推動了醫療電纜在診斷成像、病人監護和手術器械等各種應用領域的需求。醫療電纜,包括資料線、電源線和連接解決方案,是醫療設備功能不可或缺的一部分。中國、印度、日本和韓國等國家是該市場的主要貢獻者,它們在醫療技術方面的投資不斷增加,醫療器材製造規模也不斷擴大。此外,微創手術的日益普及和遠距醫療的興起,進一步擴大了對高性能、耐用醫療電纜的需求。受這些因素影響,預計亞太地區醫療電纜市場將在未來幾年繼續擴張,為醫療技術領域的製造商和利害關係人帶來機會。
亞太醫療電纜市場細分分析:
有助於得出醫療電纜市場分析的關鍵部分是類型、應用和最終用戶。
按類型分類,醫療線市場分為一次性醫療線纜、可重複使用醫療線和客製化醫療線。 2023年,可重複使用醫療線佔了最大的市場佔有率。
根據應用,醫療電纜市場細分為診斷、電動設備、病人監護、手術和生命維持等。 2023年,手術和維生系統佔據了最大的市場佔有率。
按最終用戶分類,醫療電纜市場可分為醫院和診所、門診手術中心、診斷實驗室和影像中心以及其他領域。 2023年,醫院和診所佔據了最大的市場。
亞太醫療電纜市場展望
受技術進步、人們對遺傳疾病認知的不斷提高以及個性化醫療需求的不斷成長的推動,亞太地區的醫療電纜市場正經歷強勁成長。推動這一成長的關鍵因素包括遺傳疾病患病率的不斷上升、基因組研究的進展以及應用領域的不斷擴展,例如醫療電纜的微型化正在徹底改變其設計和性能。這些進步催生了對更高效率、多功能性和微創性的需求。高品質微線在各種醫療應用中提供靈活性、可靠性和增強的效能。這些微線纜因其更輕、更薄、更易於操作的特性,被用於微創外科手術、診斷影像和穿戴式健康技術。將這些醫療設備與先進的醫療線整合,可以增強其在複雜訊號傳輸中的性能,同時又不損害安全性或功能性。這些應用包括機器人輔助手術、腹腔鏡手術和其他微創手術,這些手術受益於精準度,同時對切口周圍組織的損傷更小。它們可應用於導管介入治療,甚至是內視鏡成像系統,在這些系統中,緊湊性和靈活性對於接觸人體較小或難以觸及的部位至關重要。
這些技術進步,例如先進的材料和工程解決方案,催生了對微型電纜的需求。尖端微型電纜產品製造採用特定的生物相容性材料,包括醫用級矽膠和熱塑性彈性體,以提高產品安全性和耐用性。此外,這些電纜的電磁屏蔽性能也得到了改進,以保持核磁共振和超音波等成像技術中的訊號完整性。這些應用包括穿戴式健康設備,例如智慧手錶或遠端病人監護設備,它們透過藍牙或Wi-Fi連接,並透過先進的微型電纜解決方案實現即時健康追蹤和慢性病管理。
先進的微型電纜使微型內視鏡和手持式超音波設備等成像系統實現了小型化,適用於狹小且受限的醫療空間,並實現了最佳成像品質。這些系統在門診和即時診斷中越來越受歡迎,預計將促進醫療電纜市場的成長。此外,訊號性能和靈活性的提升也體現在最新的高性能微型電纜上,與同類產品相比,其表面尺寸更小,凸顯了微型化和高品質微型電纜在醫療電纜市場的發展趨勢。隨著主流醫療保健向微創和改進的診斷成像方向發展,先進的微型電纜解決方案預計將在未來幾年為癌症診斷、產前篩檢和代謝紊亂檢測等市場成長做出貢獻。政府推廣個人化醫療的措施也促進了基因檢測在臨床實務中的應用。包括Eurofins Scientific、23andMe和Illumina在內的市場領導者在提供廣泛的檢測服務方面處於領先地位,為市場的發展做出了貢獻。預計持續的創新以及測試準確性和可負擔性的提高將進一步推動這一成長。
亞太地區醫療電纜市場國家洞察
按國家分類,亞太醫療電纜市場包括中國、日本、印度、澳洲、韓國和亞太其他地區。中國在2023年佔最大佔有率。
根據2023年發表的《2020年中國卒中負擔估算》研究,2020年中國40歲及以上人群中卒中發生率為340萬,患病率為1780萬,死亡人數為230萬。每年有近200萬人首次經歷中風。醫療線連接影像設備,實現快速資料傳輸,用於診斷。它們還連接監測系統和治療設備,確保即時監測患者並有效實施治療,這對於有效的中風管理至關重要。
包括心血管疾病 (CVD) 在內的慢性病盛行率不斷上升,使得使用依賴可靠醫療電纜系統的先進醫療監測和治療設備成為必要。心血管疾病是中國醫療負擔的主要原因。該疾病的盛行率和發生率在全國範圍內持續上升。根據2022年4月發表的題為《中國心血管疾病死亡率和潛在風險因素:基於灰色關聯分析的多維度評估》的研究文章,心血管疾病是中國主要的醫療保健問題之一。醫療線促進了診斷設備之間的連接,確保了對心臟活動的準確監測。它們有助於連接治療設備進行治療,實現即時資料傳輸,從而增強心血管疾病患者的護理和管理。此外,根據2020年發表的一項名為《中國慢性病與老化》的最新研究,中國人口正在老化,慢性病的盛行率日益上升。預計從2010年到2040年,中國60歲以上人口比例將從12.4%(1.68億)上升至28%(4.02億)。在中國,60歲及以上人口約80%的死亡是由慢性疾病引起的,其中最常見的疾病是中風、缺血性心臟病和慢性阻塞性肺病(COPD)。
亞太醫療電纜市場公司簡介
市場上的一些主要參與者包括 TE Connectivity Ltd、深圳市永強富實業有限公司、Spacelabs Healthcare、Ametek Inc、ATL Technology、Amphenol Alden Products、Molex LLC 和 New V-Key Technology Co., Ltd 等。這些參與者正在採取擴張、產品創新和併購等各種策略,為消費者提供創新產品並增加市場佔有率。
亞太醫療電纜市場研究方法:
本報告中的資料收集和分析遵循了以下方法:
二手資料研究:研究流程始於全面的二手資料研究,利用內部和外部資源收集每個市場的定性和定量資料。常用的二手資料研究來源包括但不限於:
公司網站、年度報告、財務報表、經紀商分析和投資者介紹。行業期刊及其他相關出版品。政府文件、統計資料庫和市場報告。針對在市場營運的公司的新聞文章、新聞稿和網路廣播。註:公司簡介部分所包含的所有財務資料均已標準化為美元。對於以其他貨幣報告的公司,數據已使用相應年份的相關匯率轉換為美元。
一手研究 Insight Partners 每年都會與行業利益相關者和專家進行大量的一手調查,以驗證其資料分析,並獲得寶貴的見解。這些研究訪談旨在:
驗證並完善二手資料研究的結果。提升分析團隊的專業知識和市場理解。深入了解市場規模、趨勢、成長模式、競爭動態和未來前景。一手資料研究透過電子郵件互動和電話訪談進行,涵蓋不同地區的各種市場、類別、細分市場和次細分市場。參與者通常包括:
產業利害關係人:副總裁、業務發展經理、市場情報經理和國家銷售經理外部專家:估值專家、研究分析師和具有行業專業知識的關鍵意見領袖
The Asia Pacific medical cables market size is expected to reach US$ 3,579.01 million by 2031 from US$ 2,209.10 million in 2023. The market is estimated to record a CAGR of 6.2% from 2023 to 2031.
Executive Summary and Asia Pacific Medical Cables Market Analysis:
The Asia Pacific medical cables market is experiencing significant growth due to the increasing demand for advanced medical devices and technological innovations in healthcare. The region's rising healthcare infrastructure, along with the expanding elderly population, is driving the need for medical cables in various applications such as diagnostic imaging, patient monitoring, and surgical instruments. Medical cables, including data cables, power cables, and connectivity solutions, are integral to the functionality of medical equipment. Countries like China, India, Japan, and South Korea are key contributors to the market, with increasing investments in healthcare technologies and expanding medical device manufacturing. Additionally, the growing trend of minimally invasive surgeries and the rise of telemedicine are further augmenting the demand for high-performance, durable medical cables. With these factors, the Asia Pacific medical cables market is expected to continue expanding in the coming years, presenting opportunities for manufacturers and stakeholders in the medical technology sector.
Asia Pacific Medical Cables Market Segmentation Analysis:
Key segments that contributed to the derivation of the medical cables market analysis are type, application, and end user.
By type, the medical cables market is segmented into disposable medical cable, reusable medical cables, and custom medical cables. The reusable medical cables held the largest share of the market in 2023.
By application, the medical cables market is segmented into diagnostics, motorized equipment, patient monitoring, surgical and life support, and others. The surgical and life support held the largest share of the market in 2023.
By end user, the medical cables market is segmented into hospital and clinics, ambulatory surgical centers, diagnostic laboratories and imaging centers, and others. The hospitals and clinics segment held the largest share of the market in 2023.
Asia Pacific Medical Cables Market Outlook
The medical cables market in Asia Pacific is experiencing strong growth, driven by technological advancements, increasing awareness of genetic conditions, and the rising demand for personalized healthcare. Key factors contributing to this growth include the increasing prevalence of genetic disorders, advancements in genomic research, and the expansion of applications such the miniaturization of medical cable is transforming its design and performance. These advancements are resulting in the demand for heightened efficiency, versatility, and minimum invasiveness. The high-quality micro-cables provide flexibility, reliability, and enhanced performance across various medical applications. These micro-cables are used in minimally invasive surgical procedures, diagnostic imaging, and wearable health technologies owing to their lighter, thinner, and easier-to-maneuver properties. Integration of these medical devices with advanced medical cables amplifies their performance in complex signal transmission without damage to safety or functionality. These applications include surgery via robotic assistance, laparoscopic tools, and other minimally invasive procedures, which benefit from precision but much less damage to tissues surrounding the incision. They find applications in catheter-based interventions and even in endoscopic imaging systems, where compactness and flexibility are crucial for accessing the small or hard-to-reach parts of the human body.
These technical advancements, such as advanced materials and engineering solutions, create the demand for micro-cabling. The leading-edge manufacturing of micro-cable products utilizes specific biocompatible materials, including medical-grade silicone and thermoplastic elastomers, to make their products safer and more durable. Moreover, these cables have improvement in their electromagnetic shielding to maintain signal integrity in imaging technologies such as MRI and ultrasound. These include applications on wearable health devices such as smartwatches or remote patient monitoring devices, connected via Bluetooth or Wi-Fi, enabled through advanced micro-cabling solutions, giving real-time health tracking and chronic disease management.
Advanced micro-cables have enabled the miniaturization of imaging systems such as micro-endoscopes and handheld ultrasound devices for small and confined medical spaces, along with optimal imaging quality. These systems are gaining popularity in outpatient settings and point-of-care diagnostics and are expected to contribute to the medical cable market growth. Furthermore, the improvement in signal performance and flexibility encompasses the latest high-performance micro-cable that minimizes surface dimensions in comparison to its larger counterparts, highlighting the trend of miniaturization as well as high-quality micro-cables to the medical cable market. With mainstream healthcare converging toward minimal invasiveness and improved diagnostic imaging, advanced micro-cabling solutions are expected to contribute the market growth in coming years as cancer diagnosis, prenatal screening, and metabolic disorder testing. The adoption of genetic testing in clinical practice is also facilitated by government initiatives promoting personalized medicine. Leading players in the market, including Eurofins Scientific, 23andMe, and Illumina, are at the forefront of providing a wide range of testing services, contributing to the market's development. This growth is expected to be further fueled by continuous innovation and improvements in testing accuracy and affordability.
Asia Pacific Medical Cables Market Country Insights
Based on country, the Asia Pacific medical cables market comprises China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held the largest share in 2023.
According to the study titled "Estimated Burden of Stroke in China in 2020," published in 2023, China recorded the incidence of stroke at 3.4 million, prevalence at 17.8 million, and mortality at 2.3 million among people aged 40 years and above in 2020. Every year, nearly 2,000,000 people experience their first stroke. Medical cables connect imaging devices, enabling rapid data transmission for diagnosis. They also link monitoring systems and therapeutic devices, ensuring real-time patient monitoring and efficient delivery of treatments crucial for effective stroke management.
The rising prevalence of chronic diseases, including cardiovascular diseases (CVDs), necessitates the use of sophisticated medical monitoring and treatment devices that depend on reliable medical cabling systems. CVD is the leading cause of healthcare burden in China. The prevalence and incidence of this disease continue to rise across the country. As per the research article titled "Cardiovascular Disease Mortality and Potential Risk Factor in China: A Multi-Dimensional Assessment by a Grey Relational Approach," published in April 2022, CVD is one of the major healthcare concerns in the country. Medical cables facilitate connections between diagnostic equipment, ensuring accurate monitoring of heart activity. They help link therapeutic devices for administering treatments, enabling real-time data transmission that enhances patient care and management in cardiovascular disease. Additionally, according to a recent study, "Chronic Illness and Ageing in China," published in 2020, China's population is aging, and chronic illnesses are increasingly prevalent. From 2010 to 2040, it is estimated that the proportion of people aged 60 years and above in China will rise from 12.4% (168 million) to 28% (402 million). In the country, ~80% of deaths in people aged 60 years and above are caused by chronic diseases, the most prevalent diseases being stroke, ischemic heart disease, and chronic obstructive pulmonary disease (COPD).
Asia Pacific Medical Cables Market Company Profiles
Some of the key players operating in the market include TE Connectivity Ltd; Shenzhen Yong Qiang Fu Industry Co.; Ltd; Spacelabs Healthcare; Ametek Inc; ATL Technology; Amphenol Alden Products; Molex LLC; and New V-Key Technology Co., Ltd among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
Asia Pacific Medical Cables Market Research Methodology :
The following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Company websites , annual reports, financial statements, broker analyses, and investor presentations. Industry trade journals and other relevant publications. Government documents , statistical databases, and market reports. News articles , press releases, and webcasts specific to companies operating in the market. Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.
Primary Research The Insight Partners' conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:
Validate and refine findings from secondary research. Enhance the expertise and market understanding of the analysis team. Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects. Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
Industry stakeholders : Vice Presidents, business development managers, market intelligence managers, and national sales managers External experts : Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise